SCHEMBL4011376

SCHEMBL4011376

Cc1cc(/C=C/C(=O)O)cc(C)c1C=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2B6 P20813 1/20 0.48
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 6/20 0.47
HSD17B10 Q99714 4/20 0.47
HPGD P15428 3/20 0.47
PKM P14618 3/20 0.47
HTR1A P08908 1/20 0.47
HTR2C P28335 1/20 0.47
PTGS1 P23219 1/20 0.47
PTGS2 P35354 1/20 0.47
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC1 Q13547 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC10 Q969S8 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4011383 1.00 CYP3A4 (0.48) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL1858285 0.85 ALDH1A1 (0.47) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL1858286 0.85 ALDH1A1 (0.47) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL10018814 0.82 CYP3A4 (0.53) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL30928335 0.82 CYP3A4 (0.53) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL1249128 0.80 TTR (0.50) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL1249131 0.80 TTR (0.50) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL3690722 0.80 CYP3A4 (0.74) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL3453700 0.80 CYP3A4 (0.74) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6
SCHEMBL15464646 0.78 KDM4E (0.50) CYP3A4CYP2C9CYP1A2CYP2D6CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2074089-B1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2013-09-18 EP disclosed
US-8222248-B2 Organic compounds NOVARTIS AG (CH) 2012-07-17 US disclosed
EP-2074089-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2009-07-01 EP disclosed
WO-2008048991-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2008-04-24 WO disclosed